光啟技術(002625.SZ):收到客户超材料航空結構產品訂貨需求
格隆匯 11 月 4日丨光啟技術(002625.SZ)公佈,公司於近日收到下屬子公司深圳光啟尖端技術有限責任公司(“光啟”)的通知,光啟收到客户A的超材料航空結構產品訂貨需求(“訂貨需求”),其中前期已明確供貨價格的產品在訂貨需求中涉及的供貨金額超過人民幣12億元,未明確部分的產品價值將根據產品的研製交付週期,雙方依照相關規定進行確定。
後續雙方將按照訂貨需求的內容陸續簽訂具體交易協議。上述事項對公司2020年的經營業績產生積極影響,並對公司未來五年經營業績產生重大影響。光啟已根據客户要求完成生產能力,包括生產組織、設備實施、人才保障、能源動力等方面的評估,以確保後續可以按照客户要求完成產品交付工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.